P

DividendsPharming

PHAR

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
2/1/2024
2/15/2024
0,09
Quarterly
11/2/2023
11/17/2023
0,09
Quarterly
8/2/2023
8/17/2023
0,09
Quarterly
5/2/2023
5/16/2023
0,09
Quarterly
2/2/2023
2/16/2023
0,09
Quarterly